Corleen M. Roche - 24 Jan 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
CFO & Secretary
Signature
/s/ Corleen Roche
Issuer symbol
CGON
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
4
Filing time
26 Jan 2024, 16:30:07 UTC
Previous filing
12 Jun 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Stock Option Award $0 +492,920 $0.000000 492,920 24 Jan 2024 Common Stock 492,920 $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on January 16, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.